Merrill S. Kies

23.0k citations

178 papers · 14.6k indexed · 3 hit papers · h-index 57

Impact in

Otorhinolaryngology top 0.01%
- Head and Neck Cancer Studies
Oncology top 0.1%
- Ear and Head Tumors
- Lung Cancer Research Studies

Papers in

Otorhinolaryngology 85
- Head and Neck Cancer Studies 83
Oncology 91
- Ear and Head Tumors 26
- Lung Cancer Research Studies 14
- Cancer Diagnosis and Treatment 11

Co-authors: Roger B. Cohen Dong M. Shin Everett E. Vokes N. Azarnia Paul M. Harari Jacek Jassem Nadia Amellal James A. Bonner
Journals: Journal of Clinical Oncology (33 papers)Cancer (23 papers)Head & Neck (21 papers)Clinical Cancer Research (11 papers)International Journal of Radiation Oncology*Biology*Physics (9 papers)
Partner nations: United States France Egypt

In The Last Decade

Merrill S. Kies

176 papers receiving 14.2k citations

Hit Papers

align trajectories log scale

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study 2008 · 494 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Journal of Clinical Oncology
2006 New England Journal of Medicine
1992 New England Journal of Medicine

Peers

Countries citing papers authored by Merrill S. Kies

Since Specialization

Citations

This map shows the geographic impact of Merrill S. Kies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merrill S. Kies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merrill S. Kies more than expected).

Fields of papers citing papers by Merrill S. Kies

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merrill S. Kies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merrill S. Kies. The network helps show where Merrill S. Kies may publish in the future.

Co-authors

The 25 scholars most cited alongside Merrill S. Kies, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Merrill S. Kies Line = papers co-authored together Merrill S. Kies links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma Clinical Cancer Research ·Kevin J. Contrera, Renata Ferrarotto, G. Brandon Gunn, Shirley Y. Su, Merrill S. Kies, Bonnie S. Glisson, Adam S. Garden, Dianna Roberts, Curtis Hanba, D. C. peta D. S. lva, Adel K. El‐Naggar, Michelle D. Williams, Shaan M. Raza, Franco DeMonte, Melissa Chen, Mark S. Chambers, Ehab Y. Hanna	2024	1
2	Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy Cancer ·Pierre Saintigny, Yoshitsugu Mitani, Kristen B. Pytynia, Renata Ferrarotto, Dianna Roberts, Randal S. Weber, Merrill S. Kies, Sankar N. Maity, Sue‐Hwa Lin, Adel K. El‐Naggar	2018	24
3	Poly ADP‐ribose polymerase‐1 as a potential therapeutic target in Merkel cell carcinoma Head & Neck ·Renata Ferrarotto, Robert J. Cardnell, Shirley Y. Su, Lixia Diao, Agda Karina Eterovic, Víctor G. Prieto, M. Kaplowitz, Jing Wang, Merrill S. Kies, Bonnie S. Glisson, Lauren A. Byers, Diana Bell	2018	9
4	Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in “Low-Intermediate Risk” Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy International Journal of Radiation OncologyBiologyPhysics ·Ryan P. Goepfert, Jan S. Lewin, Martha P. Barrow, G. Brandon Gunn, Clifton D. Fuller, Beth M. Beadle, Adam S. Garden, David I. Rosenthal, Merrill S. Kies, Vassiliki A. Papadimitrakopoulou, Stephen Y. Lai, Neil D. Gross, David A. Schwartz, Katherine A. Hutcheson	2016	44
5	Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations Clinical Cancer Research ·Yoshitsugu Mitani, Bin Liu, Pulivarthi H. Rao, Vishnupriya J. Borra, Mark Zafereo, Randal S. Weber, Merrill S. Kies, Guillermina Lozano, P. Andrew Futreal, Carlos Caulı́n, Adel K. El‐Naggar	2015	154
6	Alterations Associated with Androgen Receptor Gene Activation in Salivary Duct Carcinoma of Both Sexes: Potential Therapeutic Ramifications Clinical Cancer Research ·Yoshitsugu Mitani, Pulivarthi H. Rao, Sankar N. Maity, Yu-Chen Lee, Renata Ferrarotto, Erin Anderson, Lisa Licitra, Scott M. Lippman, Merrill S. Kies, Randal S. Weber, Carlos Caulı́n, Sue-Hwa Lin, Adel K. El‐Naggar	2014	56
7	The role of trastuzumab in the management of salivary ductal carcinomas. PubMed ·Anthony J. Perissinotti, Matthew Pierce, Nédio Jair Wurlitzerd, Adel K. El‐Naggar, Merrill S. Kies, Michael E. Kupferman	2013	34
8	Patients with Advanced Head and Neck Cancers Have Similar Progression-Free Survival on Phase I Trials and Their Last Food and Drug Administration–Approved Treatment Clinical Cancer Research ·Ignacio Garrido‐Laguna, Filip Jankú, Gerald S. Falchook, Siqing Fu, David S. Hong, Aung Naing, David Hui, Xuemei Wang, Merrill S. Kies, Razelle Kurzrock	2010	14
9	Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance Clinical Cancer Research ·Michelle D. Williams, Dianna Roberts, Merrill S. Kies, Li Mao, Randal S. Weber, Adel K. El‐Naggar	2010	99
10	Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial Journal of Clinical Oncology ·Merrill S. Kies, Floyd Christopher Holsinger, J. Jack Lee, William N. William, Bonnie S. Glisson, Heather Lin, Jan S. Lewin, Lawrence E. Ginsberg, Claude Roz eacute, Erminia Massarelli, Lauren A. Byers, Scott M. Lippman, Waun Ki Hong, Adel K. El‐Naggar, Adam S. Garden, Vassiliki A. Papadimitrakopoulou	2009	187
11	Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study Journal of Clinical Oncology ·Ezra E.W. Cohen, Lee S. Rosen, Everett E. Vokes, Merrill S. Kies, Arlene A. Forastiere, Francis P. Worden, Madeleine Kane, Eric J. Sherman, Sinil Kim, Paul Bycott, Michael A. Tortorici, David R. Shalinsky, Katherine Liau, Roger B. Cohen Hit paper breakdown →	2008	494
12	Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer Head & Neck ·Denise A. Barringer, Katherine A. Hutcheson, Erich M. Sturgis, Merrill S. Kies, Jan S. Lewin	2008	18
13	Phase I Dose Escalation and Pharmacokinetic Study of Enzastaurin, an Oral Protein Kinase C Beta Inhibitor, in Patients With Advanced Cancer Journal of Clinical Oncology ·Michael A. Carducci, Luna Musib, Merrill S. Kies, Роберто Пили, Mylene T. Truong, Julie R. Brahmer, Patricia E. Cole, Rana Sullivan, Sônia Marli Singaretti de MAURO, Alessandra B. Falcão, Nathan Enas, Vikram Sinha, Donald Thornton, Roy S. Herbst	2006	150
14	Differential expression of p63 isotypes (ΔN and TA) in salivary gland neoplasms: biological and diagnostic implications Human Pathology ·Hyung Gi Moon, Merrill S. Kies, Michelle D. Williams, Frederic Weiller, Randal S. Weber, John G. Batsakis, Adel K. El‐Naggar	2005	13
15	HER2 Expression in Salivary Gland Carcinomas Clinical Cancer Research ·Bonnie S. Glisson, A. Dimitrios Colevas, Robert I. Haddad, Captain J. Bell, Adel K. El‐Naggar, Merrill S. Kies, Rosemary Costello, 満河村, Matthew A. Arquette, Corey J. Langer, Philip C. Amrein, Marshall R. Posner	2004	158
16	Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Cancer ·Adam S. Garden, Joshua Asper, William H. Morrison, Naomi R. Schechter, Bonnie S. Glisson, Merrill S. Kies, Jeffrey N. Myers, K. Kian Ang	2004	69
17	Prioritizing treatment outcomes: Head and neck cancer patients versus nonpatients Head & Neck ·Marcy A. List, Judith Lee Smith, John Stracks, Barbara Roa Pauloski, Jerilyn A. Logemann, Donna S. Lundy, Paula A. Sullivan, 美穂濱吉, Merrill S. Kies, Everett E. Vokes	2004	66
18	Gefitinib: current and future status in cancer therapy. PubMed ·Roy S. Herbst, Merrill S. Kies	2003	17
19	Phase I Trial of Oral Estramustine and 3-hr Infusional Paclitaxel for the Treatment of Hormone Refractory Prostate Cancer Cancer Investigation ·Timothy M. Kuzel, Merrill S. Kies, Marcia Flynn-Post, Yi‐Ching Hsieh, Alfred Rademaker	2002	6
20	Evaluation of homoharringtonine efficacy in the treatment of squamous cell carcinoma of the head and neck: A phase II Illinois Cancer Council study Investigational New Drugs ·Melissa Runge‐Morris, Merrill S. Kies, Everett E. Vokes, Richard R. Blough, Hans Steiner, Richard H. Knop, Kendrith M. Rowland	1989	8

About Merrill S. Kies

Merrill S. Kies is a scholar working on Otorhinolaryngology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Oral Surgery, having authored 178 papers that have together received 14.6k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (83 papers), Salivary Gland Tumors Diagnosis and Treatment (38 papers), Head and Neck Surgical Oncology (35 papers), Lung Cancer Treatments and Mutations (29 papers), Ear and Head Tumors (26 papers), Lung Cancer Research Studies (14 papers), Oral health in cancer treatment (13 papers) and Cancer Diagnosis and Treatment (11 papers). The work is most often cited by research in Otorhinolaryngology (5.7k citations), Oncology (7.3k citations), Pulmonary and Respiratory Medicine (5.3k citations), Surgery (5.2k citations) and Speech and Hearing (606 citations). Merrill S. Kies has collaborated with scholars based in United States, France and Egypt. Frequent co-authors include Roger B. Cohen, Dong M. Shin, Everett E. Vokes, N. Azarnia, Paul M. Harari, Jacek Jassem, Nadia Amellal, James A. Bonner, Eric K. Rowinsky and Adam S. Garden. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Head & Neck, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact